NCT06772532View on ClinicalTrials.gov

A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

May 29, 2025

Study Completion Date

June 10, 2025

Conditions
Healthy
Interventions
DRUG

BI 456906 - Formulation A

Formulation A

DRUG

BI 456906 - Formulation B

Formulation B

DRUG

BI 456906 - Formulation C

Formulation C

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach/Riß

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06772532 - A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body | Biotech Hunter | Biotech Hunter